Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca's tarnished R&D image haunts its fight against Pfizer
Fierce Biotech
Monday, May 5, 2014 - 9:47am
tags:
R&D, AstraZeneca, Pfizer, M&A
Abbott taps Morgan Stanley to sell mature products - sources
Reuters
Monday, May 5, 2014 - 9:45am
tags:
Abbott Laboratories, M&A
Apple on medical tech hiring spree, a possible hint of iWatch plans
Reuters
Monday, May 5, 2014 - 8:30am
tags:
Apple, devices, iWatch
Advaxis, Inc. - “3 for 3 on Orphan Drug Requests”
Yahoo
Monday, May 5, 2014 - 8:28am
tags:
Advaxis, orphan drugs, ADXS-HPV, ADXS-cHER2
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Monday, May 5, 2014 - 8:26am
tags:
Merck, Bristol-Myers Squibb, Gilead Sciences, Roche, MK-3475, hepatitis C
GlaxoSmithKline: Bringing Focus To The Business
Seeking Alpha
Monday, May 5, 2014 - 7:53am
tags:
GSK, Novartis, restructuring
Drugmaker Pfizer's 1Q profit drops 15 pct as generic competition, other factors cut sales
Yahoo/AP
Monday, May 5, 2014 - 7:52am
tags:
earnings, Pfizer
Pfizer expected to be patient in face of AstraZeneca rejection
Yahoo/Reuters
Monday, May 5, 2014 - 7:51am
tags:
Pfizer, AstraZeneca, M&A
Ian Read: the pragmatist out to transform the drugs industry
Financial Times, UK
Sunday, May 4, 2014 - 12:00pm
tags:
Pfizer, Ian Read
Why Sovaldi shouldn't cost $84,000
Modern Healthcare
Sunday, May 4, 2014 - 11:59am
tags:
Sovaldi, hepatitis C, hepatitis, Gilead Sciences
What to Watch Monday, May 5: Earnings From Drug Giant Pfizer (video)
The Street
Sunday, May 4, 2014 - 11:50am
tags:
Pfizer, earnings
Big Pharma stands to profit by cleaning out its medicine chests
Yahoo/Reuters
Sunday, May 4, 2014 - 11:47am
tags:
Novartis - Outstanding Strategic Initiatives Rendering The Sluggish Growth Irrelevant
Seeking Alpha
Sunday, May 4, 2014 - 11:45am
tags:
Novartis
China Biotech Week In Review: Pfizer's Attempt To Acquire AstraZeneca Could Run Into Trouble
Seeking Alpha
Sunday, May 4, 2014 - 11:44am
tags:
Pfizer, AstraZeneca, Zhejiang Hisun Pharma, Ambrx, Sinovac Biotech, Hutchison MediPharma, TaiGen Biotechnology, WuXi PharmaTech, Concord Medical Services
1 Pipeline All Investors Need to Know
Motley Fool
Sunday, May 4, 2014 - 11:42am
tags:
Merck, pipelines
Novartis Earnings: What Investors Need to Know
Motley Fool
Sunday, May 4, 2014 - 11:41am
tags:
Novartis, earnings
Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Paper on H7n9
Yahoo/Benzinga
Sunday, May 4, 2014 - 11:39am
tags:
Novavax, vaccines, MERS virus
Why the Market Is Wrong About Biogen Idec Inc.
Motley Fool
Sunday, May 4, 2014 - 11:38am
tags:
Biogen Idec
Repligen: A Strong Investment For The Right Kind Of Investor
Seeking Alpha
Sunday, May 4, 2014 - 11:36am
tags:
Repligen
Sun Pharma to close its Detroit facility
DNA India
Saturday, May 3, 2014 - 11:37am
tags:
Shasun Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.